Print

Cadence Pharmaceuticals, Inc. May Buy Incline Therapeutics for up to $285 Million  
6/22/2010 6:55:01 AM

Silicon Valley / San Jose Business Journal -- Cadence Pharmaceuticals Inc. on Monday said it has acquired an option to buy Incline Therapeutics Inc.for up to $285 million.
//-->